Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
6527.TWO
STRONG BUYREMOVECrystalvue Medical Corporation · Healthcare · Taiwan · $57M · Avg Vol: $69K/d
Crystalvue Medical is a high-quality manufacturer of ophthalmic devices with decent quantitative scores. However, it is a micro-cap stock with limited liquidity and lacks any connection to our 18-month macro themes, failing the Druckenmiller lens.
COMPANY DESCRIPTION
Crystalvue Medical Corporation develops and manufactures advanced ophthalmic medical devices, specializing in automatic fundus cameras and optical coherence tomography (OCT) systems. The company's competitive moat is established through proprietary optical design, precision manufacturing, and the integration of AI-driven diagnostic software. Crystalvue operates as a high-growth niche player, supplying global medical device distributors and healthcare networks.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | — | 25.1M | 26.0M | 27.4M | 30.0M | 6.1% |
| EPS | 0.10 | 0.15 | 0.13 | 0.16 | — | 17.6% |
| Shares | — | 25.5M | 25.5M | 25.3M | 25.5M | -0.1% |
| Debt | — | 1.0M | 0.8M | 0.6M | 0.4M | -28.0% |
| Equity | — | 24.5M | 27.1M | 29.7M | 32.5M | 9.9% |
| Op CF | — | 1.6M | 4.9M | 4.8M | 4.4M | 39.0% |
| Inv CF | — | -0.1M | -0.3M | -4.1M | -5.8M | — |
| Fin CF | — | -2.0M | -1.5M | -1.8M | -2.0M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 6527.TWO are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 6527.TWO | Crystalvue Medical Corporation(you) | $57M | 81 | STRONG BUY |
| 1783.TW | Maxigen Biotech Inc. | $109M | 80 | STRONG BUY |
| 9103.TW | Medtecs International Corporation Limited | $90M | 65 | BUY |
| 4126.TWO | Pacific Hospital Supply Co., Ltd | $184M | 86 | STRONG BUY |
| 1752.TW | Nang Kuang Pharmaceutical Co., Ltd. | $104M | 62 | HOLD |
| 1565.TWO | St.Shine Optical Co.,Ltd. | $149M | 63 | HOLD |
| 4771.TW | Vizionfocus Inc. | $357M | 87 | STRONG BUY |
| 4107.TWO | Bioteque Corporation | $254M | 95 | STRONG BUY |
| 6782.TW | Visco Vision Inc. | $393M | 99 | STRONG BUY |
| 6491.TW | Pegavision Corporation | $794M | 87 | STRONG BUY |
Peer medians: ROE 3.4% · P/E 16.4x · Gross margin 42.1%